Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mattias Belting

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
Neuro-Oncology Advances|February 11, 2025
Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppressionGrzegorz Wicher, Ananya Roy, Alessandra Vaccaro, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 14, 2014
Validation of plasma proneurotensin as a novel biomarker for the prediction of incident breast cancerOlle Melander, Mattias Belting, Jonas Manjer, et al.
JAMA|October 11, 2012
Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortalityOlle Melander, Alan S Maisel, Peter Almgren, et al.
Trials|March 14, 2025
Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trialErik Ehinger, Anna Darabi, Edward Visse, et al.
Translational Oncology|June 6, 2022
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancerChristopher Godina, Vineesh Indira Chandran, Magdalena Barbachowska, et al.
Oncotarget|October 6, 2017
Tumor antigen glycosaminoglycan modification regulates antibody-drug conjugate delivery and cytotoxicityHelena C Christianson, Julien A Menard, Vineesh Indira Chandran, et al.
The Journal of Biological Chemistry|March 25, 2005
A novel mechanism for protein delivery: granzyme B undergoes electrostatic exchange from serglycin to target cellsSrikumar M Raja, Sunil S Metkar, Stefan Höning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2015
Stable Peptide of the Endogenous Opioid Enkephalin Precursor and Breast Cancer RiskOlle Melander, Marju Orho-Melander, Jonas Manjer, et al.
Cancer Research|May 21, 2016
Metastasis Stimulation by Hypoxia and Acidosis-Induced Extracellular Lipid Uptake Is Mediated by Proteoglycan-Dependent EndocytosisJulien A Menard, Helena C Christianson, Paulina Kucharzewska, et al.
Cancer Immunology Research|October 8, 2024
Complement Factor H Is an ICOS Ligand Modulating Tregs in the Glioma MicroenvironmentKarolina I Smolag, Jakub Olszowka, Rebecca Rosberg, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
Neuro-Oncology Advances|February 11, 2025
Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppressionGrzegorz Wicher, Ananya Roy, Alessandra Vaccaro, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 14, 2014
Validation of plasma proneurotensin as a novel biomarker for the prediction of incident breast cancerOlle Melander, Mattias Belting, Jonas Manjer, et al.
JAMA|October 11, 2012
Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortalityOlle Melander, Alan S Maisel, Peter Almgren, et al.
Trials|March 14, 2025
Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trialErik Ehinger, Anna Darabi, Edward Visse, et al.
Translational Oncology|June 6, 2022
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancerChristopher Godina, Vineesh Indira Chandran, Magdalena Barbachowska, et al.
Oncotarget|October 6, 2017
Tumor antigen glycosaminoglycan modification regulates antibody-drug conjugate delivery and cytotoxicityHelena C Christianson, Julien A Menard, Vineesh Indira Chandran, et al.
The Journal of Biological Chemistry|March 25, 2005
A novel mechanism for protein delivery: granzyme B undergoes electrostatic exchange from serglycin to target cellsSrikumar M Raja, Sunil S Metkar, Stefan Höning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2015
Stable Peptide of the Endogenous Opioid Enkephalin Precursor and Breast Cancer RiskOlle Melander, Marju Orho-Melander, Jonas Manjer, et al.
Cancer Research|May 21, 2016
Metastasis Stimulation by Hypoxia and Acidosis-Induced Extracellular Lipid Uptake Is Mediated by Proteoglycan-Dependent EndocytosisJulien A Menard, Helena C Christianson, Paulina Kucharzewska, et al.
Cancer Immunology Research|October 8, 2024
Complement Factor H Is an ICOS Ligand Modulating Tregs in the Glioma MicroenvironmentKarolina I Smolag, Jakub Olszowka, Rebecca Rosberg, et al.
Pageof 11